Familial Pancreatic Cancer

Area of Science:

• Oncology
• Gastroenterology
• Genetics

Background:

• Familial pancreatic cancer represents 10% of all cases.
• Pancreatic cancer has a low 5-year survival rate (7%).
• Pancreatic ductal adenocarcinoma often presents at advanced stages, limiting treatment efficacy.

Purpose of the Study:

• To review current knowledge on pancreatic cancer screening programs.
• To outline the procedures involved in pancreatic cancer screening.
• To provide an overview of existing guidelines for pancreatic cancer screening.

Main Methods:

• Literature review of recent advancements in pancreatic cancer screening.
• Analysis of screening procedures for high-risk individuals.
• Synthesis of current clinical guidelines for pancreatic cancer screening.

Main Results:

• Screening programs are essential for high-risk populations, including those with hereditary tumor syndromes.
• Screening aims to detect precursor lesions like pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and mucinous cystic neoplasm.
• Early diagnosis and treatment of precursor lesions can prevent invasive disease.

Conclusions:

• Screening programs offer a vital strategy for improving outcomes in familial pancreatic cancer.
• Early detection and management of precursor lesions are key to preventing invasive pancreatic cancer.
• Adherence to current guidelines is important for effective pancreatic cancer screening.